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Kimmen Quan, Karen M. Xu, Ron Lalonde, Zachary D. Horne, Mark E. Bernard,
Chuck McCoy, David A. Clump, Steven A. Burton and Dwight E. Heron*
Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
The aim of this study is to provide a practical approach to the planning technique
and evaluation of plan quality for the multi-lesion, single-isocenter stereotactic ablative
radiotherapy (SABR) of the lung. Eleven patients with two or more lung lesions underwent
single-isocenter volumetric-modulated arc therapy (VMAT) radiosurgery or IMRS. All plans
were normalized to the target maximum dose. For each plan, all targets were treated
to the same dose. Plan conformity and dose gradient were maximized with dose-
control tuning structures surrounding targets. For comparison, multi-isocenter plans were
retrospectively created for four patients. Conformity index (CI), homogeneity index (HI),
gradient index (GI), and gradient distance (GD) were calculated for each plan. V5, V10, and
V20 of the lung and organs at risk (OARs) were collected. Treatment time and total monitor
units (MUs) were also recorded. One patient had four lesions and the remainder had
two lesions. Six patients received VMAT and five patients received intensity-modulated
radiosurgery (IMRS). For those treated with VMAT, two patients received 3-arc VMAT
and four received 2-arc VMAT. For those treated with IMRS, two patients were treated
with 10 and 11 beams, respectively, and the rest received 12 beams. Prescription doses
ranged from 30 to 54Gy in three to five fractions. The median prescribed isodose line was
84% (range: 80–86%). The median maximum dose was 57.1Gy (range: 35.7–65.1Gy).
The mean combined PTV was 49.57 cm3 (range: 14.90–87.38 cm3). For single-isocenter
plans, the median CI was 1.15 (range: 0.97–1.53). The median HI was 1.19 (range:
1.16–1.28). The median GI was 4.60 (range: 4.16–7.37). The median maximum radiation
dose (Dmax) to total lung was 55.6Gy (range: 35.7–62.0Gy). The median mean radiation
dose to the lung (Dmean) was 4.2Gy (range: 1.1–9.3Gy). The median lung V5 was 18.7%
(range: 3.8–41.3%). There was no significant difference in CI, HI, GI, GD, V5, V10, and
V20 (lung, heart, trachea, esophagus, and spinal cord) between single-isocenter and
multi-isocenter plans. This multi-lesion, single-isocenter lung SABR planning technique
demonstrated excellent plan quality and clinical efficiency and is recommended for
radiosurgical treatment of two or more lung targets for well-suited patients.
Keywords: single-isocenter, VMAT, IMRs, multi-lesion lung cancer, plan technique and quality
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Introduction
Stereotactic ablative radiotherapy (SABR) has been shown to
be effective in treating inoperable patients with primary or
metastatic lung lesions (1, 2). Traditionally, the delivery sys-
tems for SABR include multiple coplanar and/or non-coplanar
beams and helical tomotherapy (3, 4). With recent technolog-
ical advances, volumetric-modulated arc therapy (VMAT) and
intensity-modulated radiosurgery (IMRS) have been established
as treatment techniques for delivering SABR to the lung (5–
14). They provide optimal dose distributions and precise target-
ing with excellent treatment delivery efficiency. Recent studies
have shown that single-isocenter VMAT technique is feasible and
provides highly conformal dose distributions, good plan quality,
and short treatment delivery times compared with conventional
multiple-isocenter technique for multi-target intracranial radio-
surgery (15, 16). In 2014, Zhang et al. (17) reported nine non-
small cell lung carcinoma patients treated with single-isocenter
coplanar andnon-coplanar intensity-modulated radiation therapy
(IMRT) and Tomotherapy (Version 4.2, Madison, WI). Liu et al.
(18) reported the use of single-isocenter multisegment dynamic
conformal arc (SiMs-arc), full-arc VMAT, and partial-arc VMAT
techniques for lung SABR in five patients. Similarly, we hypothe-
size that SABR delivered with single-isocenter VMAT (RapidArc,
VarianMedical Systems, PaloAlto, CA,USA) or IMRS (TrueBeam
STx linear accelerator, Varian Medical Systems, Palo, Alto, CA,
USA) is a feasible treatment technique for multi-target primary
or oligometastatic lung nodules. This technique could poten-
tially save treatment time and make treatment planning more
convenient.
Our institution has adopted single-isocenter VMAT or IMRS
technique for delivering SABR to multiple lung lesions. In this
article, we report our practical and systematic treatment plan-
ning techniques and evaluate planning qualities and dosimetric
parameters of single-isocenter VMAT or IMRS techniques versus
multi-isocenter VMAT techniques for a cohort of patients diag-
nosed with two or more primary or oligometastatic pulmonary
lesions.
Materials and Methods
Patient Characteristics
From January 2011 to September 2014, 11 patients with mul-
tiple primary or oligometastatic lung lesions were treated with
a frameless single-isocenter VMAT or IMRS radiosurgery tech-
nique. Four patients were males and seven patients were females.
The median age was 73.1 years old (range: 51–87 years old). One
patient had four lesions and the other 10 patients had two lesions.
Eight patients had lesions on the same lobe and three patients had
lesions on two adjacent lobes. Seven patients had primary lung
cancers while the remaining patients had oligometastatic disease;
one had primary colorectal cancer and two had primary head and
neck cancer. One patient had disease of unknown histology. Seven
patients had adenocarcinoma while three patients had squamous
cell carcinoma. All patients had lesions in relative proximity to
each other, which either had minimal motion or moved in the
same direction during breathing.
The decision to treat with a single isocenter was based on a
number of factors: the overall volume of the lesions, the dis-
tance between them (<7 cm), and whether the motion of the two
lesions (as characterized in a 4-dimensional computed tomogra-
phy (4D-CT) scan) was similar. Single-isocenter planning was not
attempted for targets with separation>7 cm since rotational setup
errorsmay lead to position offsets in lesions, the further away they
are from the isocenter.
Treatment Planning Techniques
Patients were immobilized with the Elekta Body Fix (Elekta
Oncology Systems, Crawley, UK) coupled with a vacuum cover
sheet to immobilize the patient in the cushion. Patients then
underwent 4D-CT scan using GE LightSpeed 16 scanner (GE
Healthcare, Waukesha, WI) under audio coaching. The respira-
tory cycle was set as 3–5 s based on an individualized natural
breathing pattern. For each patient, 10 sets of phase-sorted CT
images with a slice thickness of 2.5mm were acquired using GE
advantage 4D workstation (GE Healthcare) and imported into
Varian Eclipse treatment planning system (Varian Medical Sys-
tems, Palo Alto, CA, USA) for further processing. Gross tumor
volumes (GTVs) were contoured on CT images at phase 50%,
which represents the end of expiration. Afterwards, a customized
margin was added to generate the GITV. An isotropic direct
expansion of 5mm was used to generate the PTV. Increasing the
distance between targets potentially decreases the plan quality.
Thus, our single-isocenter technique was only used when targets
were relatively close together. However, we did not apply any spe-
cific cutoff threshold for the distance between targets. In addition,
when utilizing the single-isocenter technique, it was required that
targets were moving approximately in synchronization with each
other.
Critical structures were also delineated. Dose-control tuning
structures were then created as avoidance structures to be used in
the computer optimization of dose distribution. These structures
were intended to aid in optimizing two dose level areas: high
(~prescription dose) and low (~50% of the prescription dose).
Tuning structures were created as concentric volumetric rings.
The inner control had an inner edge at the border of the PTV
and outer edge of 7mm from the PTV. The outer control had
an inner edge of 7mm from the PTV and outer edge of 1.5 cm
away from the PTV. Since most patients had only two lesions,
the isocenter was placed at the geometric midpoint between the
lesions. Two to three coplanar 180° half arcs were used for VMAT
and 10 to 12 coplanar beams were used for IMRS with the goal of
creating a plan that accomplished optimal dose distributions with
as few arcs and beams as possible. All plans used high-intensity
flattening filter-free (FFF) mode at a dose rate of 1400 monitor
units (MUs) per minute.
Several dose prescriptions and fractionation schemeswere used
based on protocol designation or physician preference, but treat-
ment planning techniques for all patients followed the above
methodology. All plans were normalized to deliver 100% of the
prescription dose to the target maximum.
During treatment delivery, we confirmed that tumor motion
was similar to that of the 4D-CT by doing a fluoroscopy prior
to the treatment. Then we utilized the cone-beam CT (CBCT)
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and aligned it to the planning CT. If significant rotational errors
were observed, the patient setup was adjusted. If the images still
did not align properly after adjustments, we would not deliver the
treatment. No re-imaging of the patient was done mid-treatment
since it was generally faster just to complete the treatment as most
of the plans were delivered with VMAT.
The SABR treatments of four patients were also retrospectively
re-planned with multi-isocenter VMAT approach. Dosimetric
parameters (PTV volume, maximum radiation dose, mean
radiation dose, V5, V10, and V20) of organs at risk (OARs),
including lung, heart, trachea, esophagus, and spinal cord for
both single-isocenter and multi-isocenter plans were recorded for
comparison.
Plan Evaluation
The dose calculation algorithm utilized to calculate the plans
was AAA, version 11. Ideally, for all treatment plans, the PTV is
covered by 100% of the prescription dose. However, practically,
any plan with a PTV covered by more than 95% prescription dose
is acceptable. Threemajor indices, conformity index (CI), gradient
index (GI) and homogeneity index (HI), were used to evaluate the
treatment plan. CI is calculated based on International Commis-
sion on Radiation Units and Measurements 62: CI=VRx/VPTV,
where VRx is the volume of the prescription dose and VPTV is the
volume of the PTV. A perfectly conformal plan generates a CI= 1.
For less conformal plans, CI> 1 if the target volume was over-
covered by the prescription volume andCI< 1 if the target volume
was under-covered by the prescription volume. According to the
Radiation Therapy Oncology Group (RTOG) Protocol 0915, CI
<1.2 is acceptable and CI of 1.2–1.5 is minor deviation. GI is
defined as GI=V50%Rx/V100%Rx, where V50%Rx is the volume of the
50%prescribed isodose line andV100%Rx is the volume of the 100%
prescribed isodose line (19). Per RTOGprotocol 0915,GI has to be
smaller than 3–6, depending on the PTV volume. HI is defined as
HI=Dmax/DRx, where Dmax is the maximum dose and DRx is the
prescription dose and is used to evaluate the uniformity of dose
distribution within a PTV. In addition, per RTOG Protocol 0915,
lung V20 has to be smaller than 10–15%. Notably, these values
were all calculated based on single-lesion radiosurgery plans.
Treatment Delivery
All plans were created for a Varian TrueBeamTM STx linear accel-
erator (Varian Medical Systems) equipped with the Varian High
Definition 120 MLC, with 2.5-mm leaf width in the central 8 cm
of the field and 5mm in the outer portion of the field. FFF mode
was used for all patients with a maximal dose-delivery rate of
1400MU/min. If 4D-CT motion study showed tumor movement
more than 5mm, gating with Varian real-time position manage-
ment (RPM) system was required. A gating window centering at
the 50% phase of the respiratory cycle was generated so that radia-
tion was only delivered when tumor motion is within 5mm. Prior
to each treatment, on-board imaging (OBI) was performed with
CBCT scans. Appropriate shifts were made to align targets and
normal structures on OBI with those on offline planning images
to ensure appropriate patient positioning. Treatment position was
verified by both the physicist and the radiation oncologist. The
beam-on time for delivering one fraction of each single-isocenter
plans was recorded. Total MUs during one fraction of SABR deliv-
ery for both single-isocenter plans and multi-isocenter re-plans
were recorded for comparison.
Results
Treatment Planning Characteristics
The majority of tumors were of non-small cell lung origins. All
patients were treated with curative intents for either primary
lung or oligometastatic diseases. The median follow-up time
since the completion of SABR treatment was 15.8months (range:
4.2–28.8months). Table 1 outlines details of each single-isocenter
TABLE 1 | Planning details for single-isocenter plans.
Patient Number of
targets
Dose
(Gy)
Fractions Isodose
linef (%)
Lesion
location
Minimum inter-lesion
distance (cm)a
Three-dimensional
distance (cm)b
Technique Number of
arcs or beams
1 2 48 4 86 RLL 0.43 2.32 IMRS 10
2 2 48 4 85 RUL 0.3 2.65 VMAT 2
3 2 30 3 84 RUL 0.95 3.03 IMRS 11
4 2 48 4 84 RLL 1.47 3.43 VMAT 3
5 2 48 4 80 RUL – 3.73 VMAT 2
6 2 40 5 85 RLL 0.81 4.06 IMRS 12
7 2 54 3 83 RLLc 2.98 5.17 VMAT 3
8 2 48 4 80 LUL,LLL 2.97 5.63 IMRS 12
9 4 48 4 82 LULx3 LLLx1 0.21 5.74d IMRS 12
10 2 54 3 85 RUL,RLL – 6.94 VMAT 2
11 2 48 4 86 LUL – 7.21 VMAT 2
Mean 46.7 84 1.27 4.42
Median 2 48 4 84 0.88 3.90 2/12
SDe 6.6 2 1.13 1.74
Range 2–4 30–54 3–5 80–86 0.21–2.98 2.32–7.21
aThe shortest one-dimensional distance between lesion edges in an axial, sagittal, or coronal plane.
bThe three-dimensional distance between lesion centers.
cRLL, right lower lobe; RUL, right upper lobe; LLL, left lower lobe; LUL, left upper lobe.
dRepresents the longest inter-lesion distance among all four lesions.
eSD.
fThis is the isodose line that received prescription dose.
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plan such as tumor locations, radiation dose, and delivery tech-
niques. Patient 8 had four lesions treated simultaneously, while
the remainder of patients had two lesions. Three patients had
lesions in adjacent lobes. Based on the treating physician and
physicist’s discretions, six patients were treated with VMAT plans
and five were treated with IMRS. For those treated with VMAT,
two patients received 3-arc VMAT and four received 2-arc VMAT.
For those treated with IMRS, one received 11 beams while one
received 10 beams and the reminder received 12 beams. Prescrip-
tion doses ranged from 30 to 54Gy in three to five fractions. Addi-
tionally, we reported on inter-lesion distances for each patient
in two forms. The minimum inter-lesion distance is the shortest
linear distance from tumor-edge to tumor-edge in either the axial,
sagittal, or coronal planes. Three patients had lesions that were
non-coplanar. The 3-dimensional distance was calculated using
the x, y, and z coordinates of lesion centers as determined by
Eclipse. For Patient 8, the longest 3-D distance is reported among
the four lesions.
Table 2 outlines details of each multi-isocenter plan. Patients
1, 7, 9, and 11 were retrospectively re-planned with multi-
isocenter VMAT techniques. Patient 1 received 3-arc VMAT
and the others received 2-arc VMAT. The SABR dose to each
lesion ranged from 29.252 to 54Gy, delivered in three to four
fractions. Figure 1 showed both single-isocenter and multi-
isocenter treatment plans for the same target. Noticeably, the
single-isocenter plan had a smaller spread of the intermediate dose
distribution.
Dosimetric Parameters of OAR
A comparison of dose volume histogram (DVH) data for single-
isocenter and multi-isocenter plans (patients 5, 7, 10, and 11)
was listed in Table 3. Critical OARs included lung, heart, trachea,
TABLE 2 | Planning details for multi-isocenter plans.
Patient Number of
targets
Target Dose
(Gy)
Fractions Isodose
line (%)
Distance between
isocenters (cm)
Techniques Number of
arcs or beams
5 2 RUL, lesion 1 48 4 82 VMAT 2
RUL, lesion 2 48 4 80 3.7 VMAT 2
7 2 RLL, lesion 1 29.252 3 80 VMAT 3
RLL, lesion 2 54 3 83 5.2 VMAT 3
10 2 RLL, lesion 1 54 3 86 VMAT 2
RUL, lesion 2 54 3 87 6.9 VMAT 2
11 2 LUL, lesion 1 48 4 83 VMAT 2
LUL, lesion 2 48 4 80 7.2 VMAT 2
RUL, right upper lobe; RLL, right lower lobe; LUL, left upper lobe; RUL, right upper lobe.
FIGURE 1 | CT scans of the target, with a colorwash display of the dose (24Gy and above) for a 48Gy plan, showing the smaller spread of the
intermediate dose distribution in the single-isocenter plan. Left, single-isocenter plan; right, multi-isocenter plan.
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TABLE 3 | Comparison of dose volume histogram (DVH) parameters for single-isocenter versus multi-isocenter treatment plans.
Organ Plan type Volume (cm3) Dmax (Gy) Dmean (Gy) V5 (%) V10 (%) V20 (%)
Lung Single-isocenter 3233:6 (2164:5–4633:7)a 60:4 (55:1–62) 4 (3:3–6:1) 18:25 (16:4–28:7) 11 (9:9–19:1) 5:1 (3:4–8:4)
Multi-isocenter 3233:6 (2164:5–4633:7) 61:05 (59:5–66:2) 4:05 (3:3–6:5) 18:95 (17:1–28:6) 11:8 (9:4–20:8) 5:05 (3:1–9:6)
Heart Single-isocenter 862:05 (618:1–1161:9) 13:55 (2:4–18:6) 1:45 (0:2–3:9) 7:2 (0–23:2) 0:42 (0–2:5) 0 (0)
Multi-isocenter 862:15 (618:1–1161:9) 12:15 (2:5–21:1) 0:95 (0:2–3:6) 3:15 (0–23) 0:4 (0–4) 0 (0–0:008)
Trachea Single-isocenter 20:15 (11:9–23:6) 17:8 (10:4–23:6) 4:9 (2:8–7:7) 44:25 (8:6–71:2) 10:1 (0:2–18:3) 0:15 (0–3:8)
Multi-isocenter 20:15 (11:9–23:7) 18:7 (13:5–24:7) 5:4 (1:9–6:6) 52:05 (10:6–68:4) 10:85 (4:8–15:6) 0 (0–0:6)
Esophagus Single-isocenter 35:45 (15:6–104:4) 19:25 (5:4–40:3) 6:05 (2:2–14:7) 34:4 (0:5–76:3) 7:6 (0–21) 0 (0–0:06)
Multi-isocenter 35:45 (15:6–104:4) 9:4 (6:8–15) 2:6 (2:5–4:2) 23 (13:8–32:5) 0:1 (0–2:1) 0 (0)
Spinal cord Single-isocenter 36:35 (18:6–60:1) 8:25 (5:4–10:8) 2:05 (1:8–7:5) 16:45 (0:4–97:5) 0 (0–0:9) 0 (0)
Multi-isocenter 36:35 (18:6–60:1) 7:8 (5:9–9:9) 1:9 (1:6–5:4) 9:5 (1:6–61:5) 0 (0) 0 (0)
aThe data are presented as median (range).
FIGURE 2 | A DVH comparison for the target and a few organs in the same plan as in Figure 1, with the triangle symbols representing the
multi-isocenter plan, and the square symbols representing the single-isocenter plan. In this case, the single-isocenter plan was overall slightly better than
the multi-isocenter plan, and would take substantially less time to deliver.
esophagus, and spinal cord. DVH parameters reported included
irradiated organ volume, maximum radiation dose (Dmax), mean
radiation dose (Dmean), V5, V10, and V20.
Lung
V20 was smaller than 10.5% for all patients except Patient 8 with
a V20 of 20.45%. Note that this patient is the only one having
four lung lesions with a total tumor volume of 87.38 cm3. Fur-
thermore, Patient 8 had a left-sided pacemaker, which required an
upper limit of radiation dose of 2Gy. For those four patients with
both single-isocenter and multi-isocenter plans, the dosimetric
parameters for both plans were listed in Table S1 in Supplemen-
tary Material. Figure 2 showed a dose-volume histogram (DVH)
comparison for the target and a few organs in the same plan as in
Figure 1.
Heart
For those four patients with both single-isocenter and multi-
isocenter plans, the dosimetric parameters for both plans were
listed in Table S2 in Supplementary Material.
Trachea
For those four patients with both single-isocenter and multi-
isocenter plans, the dosimetric parameters for both plans were
listed in Table S3 in Supplementary Material.
Esophagus
For those four patients with both single-isocenter and multi-
isocenter plans, the dosimetric parameters for both plans were
listed in Table S4 in Supplementary Material.
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Spinal Cord
For those four patients with both single-isocenter and multi-
isocenter plans, the dosimetric parameters for both plans were
listed in Table S5 in Supplementary Material.
Treatment Plan Evaluation
We assessed each single-isocenter plan’s dose conformity for,
homogeneity within, and falloff outside the combined PTV, listed
in Table S6 in Supplementary Material. CI for all patients was
smaller than or close to 1.5. GI for all plans except the plan for
Patient 8 was approximately within the constraints corresponding
to each target volume criteria provided by the RTOG Proto-
col 0915. The details of plan evaluation parameters for multi-
isocenter plans were listed in Table S7 in Supplementary Material.
Table 4 shows a direct comparison of single-isocenter and multi-
isocenter plan evaluation parameters.
Total Monitor Units and Treatment Time
For single-isocenter plans, themedian treatment time for one frac-
tion of SABR delivery was 6.4min (range: 2.7–19min) for those
treated with VMAT and was 19.1min (range: 8.3–40.9min) for
those treatedwith IMRS. Themedian totalMUs for one fraction of
SABR delivery was 4423MUs (range: 3106–6049MUs) for those
treated with VMAT and was 5831MUs (range: 4537–11449MUs)
for those treatedwith IMRS. Formulti-isocenter plans, themedian
total MUs was 8116MUs (range: 6016–9950MUs). The details
were listed in Table 5.
Discussion
This multi-lesion, single-isocenter VMAT or IMRS SABR plan-
ning technique produces plans of high quality and excellent clin-
ical efficiency, especially when combined with a high-intensity
FFF beam with a maximal dose-delivery rate of 1400MU/min.
It is a potential replacement for multi-isocenter techniques for
multiple targets in selected candidates. In this report, we presented
a systematic framework for the creation of single-isocenter VMAT
or IMRS plans for the treatment of multiple lung lesions.
This single-isocenter approach improves clinical efficiency sig-
nificantly. For the treatment of multiple brain tumors, Clark et al.
showed that the triple-arc single-isocenter VMAT plan had a
delivery time of 6min, while the triple-arc triple-isocenter VMAT
plan had a delivery time of 14 min (15). Nath et al. reported a
median delivery time of 21min using the single-isocenter IMRS
technique to treat five lesions, while the four-isocenter IMRS tech-
nique took about 38min (20). From our experience, the single-
isocenter VMAT or IMRS technique for the treatment of multiple
lung tumors also took much less time than the multi-isocenter
technique, as evidenced by our recorded treatment time. At our
institution, we often use two to three 180° arcs for the VMAT
technique and 10–15 beams for the IMRS technique. Each arc
takes about 1.5–2min to finish. Around 6min is required to finish
three arcs with a single-isocenter plan.With the conventional two-
isocenter approach for two lung lesions, 12min would be required
to finish the treatment, not accounting for the setup time for the
second isocenter. Similarly, single-isocenter approach with IMRS
will also decrease the treatment time substantially. Improved
clinical efficiency is seen when combining the single-isocenter
setup with a linear accelerator equipped with high-intensity FFF
technology delivering 1400MU/min. Decreasing the treatment
time may reduce intrafraction motion, which may allow reduced
PTVmargins in some patients. In addition, it is difficult for many
patients with advanced lung disease to lie flat for extended periods
of time. Reducing the treatment time may translate to improved
patient comfort and easier radiation delivery.
TABLE 5 | Treatment time and total monitor units for single-isocenter and
multi-isocenter plans.
Patient Single-isocenter Multi-isocenter
Treatment
modality
Time
(min)
Total
MUs
Treatment
modality
Total
MUs
1 IMRS 16:22 4537
2 VMAT 7:09 4957
3 IMRS 8:34 5831
4 VMAT 3:17 3691
5 VMAT 2:66 3106 VMAT 7699
6 IMRS 40:88 11449
7 VMAT 18:94 5304 VMAT 9950
8 IMRS 19:11 5350
9 IMRS 23:06 8071
10 VMAT 5:61 6049 VMAT 8533
11 VMAT 13:89 3889 VMAT 6016
TABLE 4 | Comparison of plan evaluation parameters for single-isocenter versus multi-isocenter treatment plans.
Target Combined PTV (cm3) Conformity index Homogeneity index Gradient index Gradient distance (cm)
5 Single-isocenter 14.9 1.19 1.25 5.72 1.25
RUL, lesion 1 5.6 1.22 0.94 6.98 1.14
RUL, lesion 2 9.3 1.25 1.17 6.49 0.97
7 Single-isocenter 46 1.21 1.2 4.16 1.41
RLL, lesion 1 10.9 1.13 1.25 4.34 1.17
RLL, lesion 2 35.1 1.22 1.20 4.64 0.96
10 Single-isocenter 15.21 1.53 1.18 6.10 1.45
RLL, lesion 1 7.3 1.14 1.16 5.34 0.93
RUL, lesion 2 8 1.14 1.15 5.60 0.99
11 Single-isocenter 75.18 0.97 1.16 4.41 1.64
LUL, lesion 1 40.4 2.84 1.20 3.76 1.21
LUL, lesion 2 34.7 1.27 1.25 4.12 1.29
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Four-dimensional computed tomography has become the stan-
dard radioimaging tool for assessing lung tumor volume, posi-
tion, and motion during treatment planning (21). Although it is
assumed that the tumor motion captured with 4D-CT at the time
of planning is representative of tumor motion during treatment,
changes in respiratory patterns have been observed in patients
undergoing conventionally fractionated radiotherapy (22, 23).
The resulting geographic errors can compromise local control
and cause unnecessary irradiation of healthy tissues, increas-
ing the chance of radiation toxicity. Reducing the treatment
time decreases the likelihood of changes in respiratory patterns
from coughing or discomfort and makes geographic miss less
likely (24).
In thoracic radiotherapy, radiation pneumonitis and pul-
monary fibrosis are the most common and the major dose-
limiting toxicities (25). Lung V20 and V5 are potential predictors
of the risk for radiation-induced pneumonitis. Lung V20 should
be less than 10% and lung V5 should be less than 40% (26) to
minimize the likelihood of developing symptomatic pneumonitis
(27, 28). Except Patient 8 (four lesions), V20 for all patients was
lower than or close to 10.5% andV5 for all patients was lower than
40%. No patient developed symptomatic radiation pneumonitis
after receiving treatment. Moderate dose spills outside the PTV
can be correlated with a higher risk of complications. The GI
is an excellent surrogate for the evaluation of dose spill. Per
RTOG protocol 0915, a constraint for GI exists, depending on
the PTV volume. For PTV values ranging from 13.2 to 95 cm3,
the upper limit of GI ranges from 4.4 to 5.8. Except Patients 7
and 8, all patients had a GI within this range, which translates
to minimal dose spill. CI for all patients was less than or close to
1.5. The lowest CI was 0.97. HI was within a range of 1.16–1.28,
corresponding to good uniformity of dose distributions within
the PTV. Gradient distance (GD) is the average distance from
100% prescribed dose to 50% prescribed dose and ranged from
1.14 to 2.69 cm among our patients. It is an indicator of how fast
the radiation dose falls off and is used to evaluate the sparing
of normal lung tissues. These parameters demonstrated that the
single-isocenter VMAT or IMRS plans created for these patients
were of excellent quality. It is worth noting that Patient 8 had a left-
sided pacemaker requiring a constraint of maximum radiation
dose of 2Gy when treating his four left-sided lung lesions. This
challenge made the plan more complicated than the rest, but the
dosimetric parameters only exceeded the constraints slightly and
no toxicity has been reported. Therefore, it is very promising
that these single-isocenter SABR of the lung plans will become
extremely customizable and widely applied. Although our study
used Varian Eclipse treatment planning software and a Varian
TrueBeam linear accelerator, the outlined treatment planning
techniques and principles should be applicable to other treatment
planning and delivery platforms. Our experience showed that the
integration of dose-control tuning structures with the optimiza-
tion goals leads to great improvement in overall plan quality and
it could be implemented on other treatment planning platforms
as well.
Another potential concern for single-isocenter treatment plans
is leakage dose from leaves moving in between tumors, which
may cause increase of the low-dose region. V5, V10, and V20
are good measures of the low-dose regions. As shown in Table 3,
our single-isocenter plans had similar or even smaller V5, V10,
and V20, compared with multi-isocenter plans. In Table S7 in
Supplementary Material, we listed the plan evaluation parameters
for multi-isocenter plans. For Patient 7, the CI for the single-
isocenter plan was 1.53, higher than those for the multi-isocenter
plan (CI= 1.14), but still within a reasonable range. GDs for
single-isocenter plans were increased compared with those of the
multi-isocenter plans, which indicated slower fall off of doses. This
suggested that single-isocenter plans may cause greater radiation
to normal lung tissues or adjacent OARs. However, as mentioned,
GIs for all single-isocenter plans except Patients 7 and 8 were
all within the constraints suggested by RTOG protocol 0915. In
addition, in Tables S1–S5 in Supplementary Material, we listed
volume, Dmax, Dmean, V5, V10, and V20 for total lung, heart,
trachea, esophagus, and spinal cord of both single-isocenter and
multi-isocenter plans. For esophagus and spinal cord, single-
isocenter plans tended to producemore radiation, butDmax values
of esophagus for all plans (except Patient 11) and spinal cord for
all plans were less than 30 and 26Gy, respectively, as suggested by
the RTOG protocol 0915.
Intensity-modulated radiosurgery allows for adjustment of the
intensity of the radiation beam so that the tumor receives a
high dose of radiation while minimizing radiation exposure to
surrounding normal tissues. Therefore, it may improve the ther-
apeutic ratio for lung cancers, increasing the beneficial effect
while minimizing the toxicity. However, highly conformal ther-
apy requires accurate target definition and assessment of target
motion. Only the tissues identified as the target will receive ther-
apeutic dose and slight geographic error may lead to significant
toxicities (29). In addition, the planning and quality assurance
processes are very complex and time-consuming. A recent report
by Zhang et al. introduced the single-isocenter technique for
treating two or three lung lesions in nine patients with IMRS
or tomotherapy. However, nine static beams were used in all
of their plans while the beam number in our IMRS plans was
individualized, with a range of 10–12 beams. Using more beams
improves plan quality and the required number of beams depends
directly on the complexity of the fluence profiles that can be
deliveredwithin the physical and technical constraints of the treat-
ment machine (30). On the other hand, VMAT has a much faster
delivery time and also has the ability to achieve highly conformal
dose distributions. It is considered as an alternative form of IMRS
(31). A recent report by Liu et al. showed that additional intensity
modulation allowed VMAT to produce dosimetrically improved
plans than the SiMs-arc techniques in five patients (18). It was also
noted that due to inverse planning with overlapping arcs, half-arc
VMAT may produce potentially more superior treatment plans
than full-arc VMAT. However, unlike our plans, the isocenter of
the half-arc VMAT plans reported in Liu et al. was placed inside
the PTV. In addition, all five patients mentioned in Liu et al.
had two lesions on the same lobe while one patient in our report
had two lesions on adjacent lobes. The choice of IMRS or VMAT
depends on the specific treatment planning goals and preferences
of the radiation oncologist and the physicist.
However, this single-isocenter SABR of the lung technique does
have several limitations, including potential setup errors, motion
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errors, and rotational errors. For two lesions, the isocenter is
usually placed at the midpoint of the lesions. With multiple (4)
non-coplanar lesions, sometimes it can be difficult to determine
the optimal position for the isocenter. As we mentioned previ-
ously, some variability exists in respiratory patterns between the
treatment and the planning sessions. Due to the high conformity
of IMRS and VMAT, even slight motion error can lead to a sig-
nificant risk of geographic miss and toxicities. In addition, lesions
separated by more than a few centimeters may exhibit different
respiratory motions, requiring careful definition of PTV margins
for each. Dose distribution for this technique is also very sensitive
to rotational errors, especially for small lesions and those distant
from the isocenter. Therefore, great care must be taken to ensure
accurate imaging guidance and patient positioning for this single-
isocenter multi-target technique. Increasing the distance between
targets potentially decreases the plan quality. Thus, our single-
isocenter technique was only utilized when targets were relatively
close together. However, we did not apply any cutoff threshold
for the distance. In addition, before the treatment planning, an
evaluation of each target’s motion was made with the 4D-CT to
determine whether targets were moving in synchronization with
each other, an ideal scenario for our single-isocenter technique.
Conclusion
Our report is the largest series so far to introduce the single-
isocenter SABR of the lung with VMAT or IMRS. In addition,
we report the very first single-isocenter IMRS plan for four lung
lesions on two adjacent lobes. Compared to previous studies, our
treatment plans use better techniques, including individualizing
and increasing the beam number in IMRS and applying half-
arc VMAT with the isocenter placed outside the PTV. We also
compared plan evaluation parameters and dosimetric parameters
between single-isocenter andmulti-isocenter plans. The results of
our report showed that this technique produces plans of favorable
CI, GI and HI values, which are surrogates of high clinical quality.
We have introduced a practical and systematic framework for
radiation oncologists, physicists, and dosimetrists to utilize when
creating single-isocenter VMATor IMRS lung radiosurgery plans.
The excellent plan quality and clinical efficiency makes single-
isocenter approach a potential replacement for the currently
adopted multi-isocenter approach.
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